Showing 2111-2120 of 4064 results for "".
Addressing the Psychosocial Impacts of IBD
https://reachmd.com/programs/crohns-colitis-foundation-perspectives/addressing-the-psychosocial-impacts-of-ibd/10711/Did you know that 35% of IBD patients have symptoms of anxiety? That’s why it’s so important to know how to care for your patients’ body AND mind.IQ vs. EQ: Is Emotional Intelligence Just as Important?
https://reachmd.com/programs/primary-care-today/iq-vs-eq-is-emotional-intelligence-just-as-important/10624/Most of the work we do in school looks to our IQ for our understanding, but should we be recognizing emotional intelligence in everyday life?Can an iPad Game Help Treat Lazy Eye in Children?
https://reachmd.com/programs/the-jama-report/can-ipad-game-help-treat-lazy-eye-children/8415/A new study in JAMA looked at whether a special type of iPad game could be a new way to treat lazy eye.Pain Boot Camp
https://reachmd.com/programs/clinicians-roundtable/pain-boot-camp/2914/What else can you do to help rid your patient of chronic pain? Send them to camp. Boot camp. Pain boot camp. In this segment, learn about an interdisciplinary method to evaluate and treat pain from our guest Dr. Steven Stanos, Medical Director of the RIC Center for Pain Management. In pain boot campInnovations in Oncology Learning Center: From Guidelines to Practice: Melanoma
https://reachmd.com/programs/cme/innovations-in-oncology-learning-center-from-guidelines-to-practice-melanoma/33212/Explore guideline-based treatment strategies and clinical data to optimize guideline-concordant care for patients with melanoma in the neoadjuvant, adjuvant, and metastatic settings.At the Lid Line: Unmasking Demodex Across the OSD Spectrum
https://reachmd.com/programs/cme/at-the-lid-line-unmasking-demodex-across-the-osd-spectrum/54261/Join Drs. Devries and Koetting evaluate screening methods for accurate diagnosis of Demodex blepharitis and optimal treatment strategies for this condition.The Fifth Pillar? Closing the Gap in HFrEF
https://reachmd.com/programs/cme/the-fifth-pillar-closing-the-gap-in-hfref/37615/Experts discuss emerging heart failure data, outline clinical significance, and address patient care needs, featuring insights presented at HFSA 2025.Safety First: Navigating CELMoD-Associated Toxicities
https://reachmd.com/programs/cme/safety-first-navigating-celmod-associated-toxicities/36571/Beyond the Horizon in Multiple Myeloma: Harnessing Novel CELMoD Mechanisms for Increased Antimyeloma ActivityThe IL-36 Connection: Immunology’s Role in GPP Pathogenesis and Therapy
https://reachmd.com/programs/cme/il-36-gpp-pathogenesis-therapy/54775/Generalized pustular psoriasis (GPP) can look familiar but missing it can have serious consequences. Uncover how IL-36 signaling and immune dysregulation shape disease presentation, progression, and treatment response. You’ll learn to distinguish GPP from other neutrophilic dermatoses using clinicalOCT Biomarkers as Predictors of Treatment Response in RVO-Related Macular Edema
https://reachmd.com/programs/eye-on-ocular-health/oct-biomarkers-as-predictors-of-treatment-response-in-rvo-related-macular-edema/37664/Retinal vein occlusion (RVO) is a leading cause of sudden vision loss, often complicated by macular edema that affects patient outcomes. While treatment options like anti-vascular endothelial growth factor agents and corticosteroid implants exist, predicting response remains a challenge. Hear Dr. Mi